QIAGEN and 10x Genomics enter collaboration

Netherlands-based company QIAGEN will collaborate with California’s 10x Genomics on the development and promotion of next-generation sequencing (NGS), single-cell biology and bioinformatics solutions.

The companies plan to co-develop a comprehensive portfolio of products to improve sample preparation, sequencing and single-cell analysis to further enhance the information that their customers can derive from their research. As part of this, products from each company will be optimised for use with complementary systems developed by the other collaborator.

The two companies will also co-market each other’s applications, including:

• QIAGEN’s MagAttract HMW DNA kits;
• QIAGEN’s NGS and bioinformatics solutions;
• 10x’s Chromium product suite for single-cell analysis;
• 10x’s GemCode molecular barcoding and analysis platform.

“We welcome the opportunity to partner with QIAGEN, with their comprehensive offerings for genomic analysis, ranging from sample preparation technologies to bioinformatics solutions for the interpretation and analysis of genomic data,” said 10x CEO Serge Saxonov. “Access to long-range sequence information is becoming the standard for obtaining the most comprehensive understanding of disease, and we expect this collaboration to allow our respective customers to gain valuable insights that have previously not been possible.”

“QIAGEN’s collaboration with 10x Genomics enables both companies to better serve its customers, helping them make groundbreaking advances in single-cell biology, bioinformatics and beyond,” said QIAGEN CEO Peer Schatz. “10x Genomics is recognised for delivering critical long-range sequence information that greatly expands the quality of genome research. This partnership will further the potential of each of our product lines while providing significant new capabilities to NGS researchers.”